A dietary and exercise intervention slows menopause-associated progression of subclinical atherosclerosis as measured by intima-media thickness of the carotid arteries  by Wildman, Rachel P. et al.
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Dietary and Exercise Intervention
lows Menopause-Associated Progression
f Subclinical Atherosclerosis as Measured by
ntima-Media Thickness of the Carotid Arteries
achel P. Wildman, PHD,* Laura L. Schott, MA,† Sarah Brockwell, PHD,† Lewis H. Kuller, MD, DRPH,†
im Sutton-Tyrrell, DRPH†
ew Orleans, Louisiana; and Pittsburgh, Pennsylvania
OBJECTIVES The object of this study was to assess the effects of menopause and a diet/exercise intervention
on subclinical atherosclerosis progression.
BACKGROUND Subclinical atherosclerosis has been linked to higher coronary heart disease and stroke rates
and is greater among postmenopausal women according to cross-sectional analyses. Whether
menopause is associated with an accelerated progression of subclinical disease is unknown, as
is the extent to which lifestyle intervention can alter the course of progression.
METHODS Intima-media thickness (IMT) measures of the common carotid artery (CCA), internal
carotid artery (ICA), and bulb segments of the carotid arteries were measured twice during
the course of 4 years in 353 women from the Women’s Healthy Lifestyle Project, a dietary
and exercise clinical trial designed to prevent adverse risk factor changes through the
menopause. A third measure was obtained 2.5 years later for 113 women.
RESULTS The progression of IMT was observed for the average of all segments (AVG), the CCA, and
the bulb (0.007 mm/year, 0.008 mm/year, and 0.012 mm/year; p  0.01 for all), but not for
the ICA. Among controls, menopause was associated with accelerated IMT progression
(0.003 mm/year for premenopausal women vs. 0.008 mm/year for perimenopausal/
postmenopausal women for AVG IMT; p  0.049). Additionally, among the 160
perimenopausal/postmenopausal women, the intervention slowed IMT progression (0.008
mm/year for the control group vs. 0.004 mm/year for the intervention group for AVG IMT;
p  0.02). Similar results were found for the CCA and bulb segments.
CONCLUSIONS These data demonstrate that the menopause transition is associated with accelerated
subclinical atherosclerosis progression and that a diet/exercise intervention slows menopause-
related atherosclerosis progression. (J Am Coll Cardiol 2004;44:579–85) © 2004 by the
American College of Cardiology Foundationb
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iubclinical atherosclerosis has been linked to higher rates of
oronary heart disease (1), myocardial infarction (1), and
troke (2), and is considered a precursor to clinical cardio-
ascular events. Cross-sectionally, the menopause transition
as been associated with subclinical disease levels, measured
y both intima-media thickening (IMT) of the carotid
rteries and by arterial distensibility (3–6). Whether the
enopause transition is also associated with the progression
f subclinical disease has not been established.
See page 586
During the menopause transition, low-density lipoprotein
holesterol (LDL-C) levels have been shown to increase, and
igh-density lipoprotein cholesterol (HDL-C) levels have
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urgh, Pennsylvania. This research was funded by NIH Grant number HL-45167
nd AHA Grant-In-Aid 005023 6N.
Manuscript received November 25, 2003; revised manuscript received March 8,
w004, accepted March 16, 2004.een shown to decrease (7). Increased physical activity in
id-life has been shown to protect against these adverse lipid
hanges (8). Studies of mid-life have also documented sub-
tantial weight gain during this period, which has been asso-
iated with adverse changes in coronary heart disease risk
actors (9). The Women’s Healthy Lifestyle Project (WHLP)
linical trial was initiated to determine the efficacy of a dietary
nd physical activity intervention in preventing the weight gain
nd abnormal lipid profiles that occur at the time of meno-
ause. By the end of the initial six-month intensive interven-
ion period, the diet/activity intervention group achieved sig-
ificant reductions in total cholesterol, triglycerides, weight,
aist-to-hip ratio, systolic blood pressure (BP), diastolic BP,
nd serum glucose levels, and significant increases in physical
ctivity (10). The intervention group maintained significantly
ower weight, waist circumference, LDL-C, triglycerides, and
lucose at the end of the 54-month trial (11).
Repeated IMT measures within the WHLP trial in
ombination with the success of the WHLP diet/activity
ntervention on lipid profiles and weight gain provided us
ith the opportunity to assess the following questions: was
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IMT Progression and Exercise Intervention August 4, 2004:579–85rogression of carotid atherosclerosis observable in these
iddle-aged women over the course of a four-year period,
nd if so, was progression related to menopause status or a
ifestyle intervention?
ETHODS
tudy population. From 1991 to 1994, 535 women age 44
o 50 years (92% Caucasian) were randomly assigned to a
ifestyle-intervention group (n  260) or to an assessment-
nly control group (n 275). Eligible women were required
o be premenopausal (defined as 3 months of amenorrhea
n the 6 months before the telephone screening interview)
nd to have normal to high-normal ranges of diastolic BP,
ody mass index (BMI), fasting glucose, and cholesterol
evels. Exclusion criteria included hormone therapy and
urrent use of anti-hypertensive, lipid-lowering, insulin,
hyroid, or psychotropic medications. The aim of the
ntervention was to reduce total dietary and saturated fat and
holesterol, prevent weight gain, and increase physical
ctivity levels. Specific goals of the lifestyle intervention
ere a reduction of dietary fat to 25% of total fat, 7% of
aturated fat, and 100 mg of cholesterol; a reduction in
aloric intake to 1,300 kcal/day; and an increase in leisure-
ime physical activity to 1,000 to 1,500 kcal/week of energy
xpenditure. Participants who were randomized to the
ntervention program attended 15 group meetings held
uring the course of 20 weeks. Sessions were led by trained
utritional and behavioral interventionalists and were held
eekly for 10 weeks, then biweekly for the remaining 10
eeks. After this intensive intervention, participants entered
he maintenance phase of the program. Both the interven-
ion and the control groups received clinical assessments at
, 18, 30, 42, and 54 months after their date of random-
zation. Beginning in 1994, all of the women were invited to
omplete a carotid ultrasound scan. A total of 453 women
ere enrolled in the carotid study (response rate, 85%). The
tudy was approved by the Institutional Review Board at the
niversity of Pittsburgh, and all participants provided
ritten informed consent.
linical measures. Clinical measures were assessed at study
aseline and at each follow-up visit and included height, body
eight, waist circumference, hip circumference, BP measures,
nd a fasting blood draw. The BPs were measured twice using
Abbreviations and Acronyms
ARIC  Atherosclerosis Risk In Communities study
BMI  body mass index
BP  blood pressure
CCA  common carotid artery
HDL-C  high-density lipoprotein cholesterol
ICA  internal carotid artery
IMT  intima-media thickness
LDL-C  low-density lipoprotein cholesterol
WHLP  Women’s Healthy Lifestyle Projectstandard mercury sphygmomanometer after 5 min of rest. 0otal cholesterol, HDL-C, LDL-C, triglycerides, and glucose
ere determined using standard laboratory procedures. Fasting
erum insulin was measured via radioimmunoassay. The BMI
as calculated by dividing the participant’s weight in kilograms
y the square of her height in meters. Smoking status (current,
ormer, never) and history of hysterectomy and hormone
herapy use were assessed via questionnaire. Daily kilocalories
xpended through physical activity were also assessed via
uestionnaire (12).
Although hormone use was an exclusion criterion at
aseline, women were permitted to begin hormone use after
heir baseline visit. Menopause status and hormone therapy
se initiated after baseline were assessed at the time of the
lose of the intervention (54 months). One hundred and ten
omen initiated hormone use between baseline and the
4-month follow-up visit. Perimenopausal status was de-
ned as skipping a bleeding cycle or taking hormone
herapy for 3 to 11 cycles in the last year, and postmeno-
ausal defined as skipping or taking hormone therapy for 12
r more consecutive cycles. Women who had undergone a
ysterectomy were categorized as postmenopausal. Because
f the low number of perimenopausal women, menopause
tatus was collapsed into a dichotomous variable for analy-
es: premenopausal versus perimenopausal/postmenopausal.
arotid ultrasound. Initial carotid scans were performed
n 453 women an average of 2.7 years (range, 0.7 to 7.6
ears) from the baseline WHLP examination. Second scans
ere performed on 357 women an average of 3.9 years
range, 0.8 to 6.9 years) after the initial scan. The American
eart Association grant that funded this study allowed for
third scan to be performed on approximately 100 women.
herefore, the first 113 women who underwent a second
can came in for a third scan an average of 2.5 years (range,
to 3.4 years) after the second scan.
Detailed B-mode images of the right and left common
arotid artery (CCA), carotid bifurcation, and the first 1.5
m of the internal carotid artery (ICA) were obtained at
ach ultrasound visit using a Toshiba SSA-270A scanner
Toshiba America Inc., New York, New York) equipped
ith a 5-MHz linear array imaging probe. To measure the
verage IMT of each segment, lines were electronically
rawn along 1-cm segments of the lumen-intima interface
nd the media-adventitia interface of the near and far walls
f the distal CCA and along the far walls of the carotid bulb
nd ICA. The average of these was recorded for each
ocation. The mean of all average readings across the eight
ocations (four on each side) was calculated.
To assess the reproducibility of ultrasound measures, 15
articipants had carotid scans performed by two different
onographers on two occasions approximately two weeks
part, and each scan was read by two readers. When
ccounting for all sources of measurement variation, the
ntraclass correlation for average IMT was 0.88. The aver-
ge absolute difference in IMT between sonographers was
.04 mm and between readers was 0.03 mm. These values
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August 4, 2004:579–85 IMT Progression and Exercise Interventionompare favorably with those published from other research
aboratories (13,14).
tatistical analyses. Age adjustment was made using the
ge at the first ultrasound scan. Laboratory and anthropo-
etric variables were taken from WHLP study baseline as
ell as from the follow-up visit closest to the first ultrasound
can (median time between scan and closest follow-up visit
as 119 days).
All statistical analyses were performed using the SAS
ystem for Windows, version 8.2 (SAS Institute, Cary,
orth Carolina), and statistical significance was defined as p
0.05 unless otherwise defined. Wilcoxon rank sum tests
ere used to assess differences in median values between the
ntervention and control groups at the baseline visit and at
he time of the first ultrasound scan. The chi-square statistic
as used to test differences in categorical variables between
ntervention and control groups at baseline and the time of
he first ultrasound scan.
To assess IMT progression, change scores for each
oman were created from the first ultrasound visit to the
econd (value at the second scan minus value at the first
can, standardized by the time between scans) and from the
econd to the third (value at the third scan minus value at
he second scan, standardized by the time between scans) for
he 113 women who underwent three scans. To determine
hether or not IMT progression was even observed during
he follow-up interval, these change scores were averaged,
nd a one-sample student t test was performed to determine
hether changes were significantly different from zero.
To assess associations between treatment group or meno-
Table 1. Intervention and Control Group Cha
Variable
In
Average IMT (mm)
CCA IMT (mm)
ICA IMT (mm)
Bulb IMT (mm)
Age (yrs)
Systolic blood pressure (mm Hg) 1
Diastolic blood pressure (mm Hg)
Total cholesterol (mg/dl) 1
HDL cholesterol (mg/dl)
LDL cholesterol (mg/dl) 1
Triglycerides (mg/dl)
Glucose (mg/dl)
Insulin (U/ml)
Body weight (lbs) 1
Waist girth (cm)
BMI (kg/m2)
Daily kilocalories of exercise 1,2
Reached perimenopause or postmenopause*†
Undergone hysterectomy*
Hormone user*
Current smoker*
*Values are n (%). †By 54-month visit. Data are presented a
BMI  body mass index; CCA  common carotid artery
IMT  intima-media thickness; LDL  low-density lipoprause status and annual change, accounting for the corre- gation between repeated carotid change scores for those with
wo change scores, repeated measures linear modeling (SAS
roc Mixed, SAS Institute) was used. Repeated change
core models were run for each IMT measure, adjusted for
ge and the applicable IMT value at the first scan. To
ormally test whether the effects of menopause were altered
y the intervention, an interaction term between menopause
tatus and treatment group was tested, and the threshold for
ts significance was set at p 0.10. To formally test whether
he effects of the intervention among perimenopausal or
ostmenopausal women were altered by hormone use, an
nteraction term between menopause status and hormone
se was tested, and the threshold for its significance was set
t p  0.10.
ESULTS
here were 353 women with non-missing IMT data who
ad at least one change score, and all analyses used this
ubset of women. At WHLP baseline, those who were
andomized to the intervention group had a higher median
riglyceride value than those randomized to the control
roup (86.4 vs. 78.6; p  0.005). No other significant
ifferences were found between the two groups at baseline.
y the time of the first carotid scan, however, evidence of
he intervention could be seen in lower body weight values,
ower BMI, and higher daily kilocalories of exercise among
he intervention group compared with the control group
Table 1). At the time of the first ultrasound scan, IMT
alues did not differ between the intervention and control
ristics at First Ultrasound Scan
ntion Group
 166)
Control Group
(n  188) p Value
0.51–0.92) 0.67 (0.51–0.92) 0.56
0.50–0.91) 0.67 (0.51–0.91) 0.70
0.43–0.93) 0.61 (0.41–0.93) 0.78
0.47–1.41) 0.71 (0.46–1.54) 0.11
46.3–54.0) 49.0 (46.5–54.1) 0.70
79.0–153.0) 106.5 (83.0–151.0) 0.42
48.0–94.0) 70.0 (52.0–98.0) 0.99
138.0–286.0) 197.0 (119.0–271.0) 0.09
36.4–103.0) 63.3 (30.6–114.0) 0.75
60.0–170.0) 115.0 (45.0–173.0) 0.19
26.0–337.0) 80.0 (33.0–380.0) 0.96
84.0–116.0) 98.0 (78.0–138.0) 0.26
3.0–37.0) 12.0 (3.0–62.0) 0.46
110.0–211.0) 146.0 (106.0–228.0) 0.04
62.0–101.5) 76.0 (62.0–105.0) 0.13
18.3–33.9) 25.1 (18.6–35.9) 0.01
28.0–9065.0) 974.0 (0–8876.0) 0.003
45) 85 (45) 0.96
1.8) 9 (4.8) 0.12
13.3) 39 (20.9) 0.06
8.4) 20 (10.7) 0.47
n (range).
 high-density lipoprotein; ICA  internal carotid artery;racte
terve
(n
0.66 (
0.69 (
0.61 (
0.73 (
49.4 (
05.0 (
69.0 (
93.0 (
62.3 (
11.0 (
85.0 (
98.0 (
12.0 (
42.0 (
75.0 (
23.9 (
94.0 (
75 (
3 (
22 (
14 (
s mea
; HDL
otein.roups for any of the four carotid segments (Table 1).
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IMT Progression and Exercise Intervention August 4, 2004:579–85Significant progression was observed for all of the carotid
egments except for the ICA IMT. Mean annual changes
or average IMT, CCA IMT, and bulb IMT were 0.007
m/year, 0.008 mm/year, and 0.012 mm/year, respectively
p  0.01 for all).
In order to see the natural effects of menopause without
odification by the intervention, we evaluated the control
roup alone (Fig. 1). Among these women, a significant effect
f menopause was demonstrated for average IMT; women
ho had undergone the transition to perimenopause or post-
enopause had significantly larger annual changes in average
MT than women who remained premenopausal (Fig. 1).
lthough statistically significant for bulb IMT only, this
attern was present among all carotid segments (Fig. 2).
Among the whole sample, annual changes were not
ignificantly different between the intervention and control
roups (Table 2). To see the intervention effect clearly
ithout modification by menopause, intervention analyses
ere stratified by menopause status. Among premeno-
ausal women, no intervention effect was present for any
arotid segment. However, among perimenopausal/
ostmenopausal women, the intervention group demon-
trated significantly less progression than the control group
Fig. 2). Although statistically significant for average IMT
nd bulb IMT only, this pattern was present among all
arotid segments (Fig. 2). The significant intervention effect
mong women who had undergone the transition to peri-
enopause and postmenopause indicates that the exercise
nd dietary intervention slowed the menopause-associated
MT progression. The differential intervention experience
f premenopausal versus perimenopausal/postmenopausal
omen was confirmed by statistically significant treatment-
y-menopause-status interaction terms for average IMT
nd bulb IMT in mixed modeling (p  0.060 for average
MT and p  0.030 for bulb IMT).
Hormone therapy use that was initiated after baseline was
dded to the above models and was not significantly
ssociated with IMT progression, nor did it noticeably alter
igure 1. Mean annual intima-media thickness (IMT) changes (in mm
orresponding baseline intima-media thickness. Gray bars  premenopau
rtery; ICA  internal carotid artery.he results described above. Additionally, among perimeno- tausal/postmenopausal women, hormone use did not alter
he effect of the intervention as tested by a hormone-by-
reatment interaction term.
ISCUSSION
mong these middle-aged women, our data document the
easurable progression of average IMT, CCA IMT, and
ulb IMT during a four-year follow-up period. These data
lso document the expected effect of menopause, with
reater subclinical disease progression among women who
ad undergone the transition to perimenopause or post-
enopause than among women who remained premeno-
ausal. Importantly, these data also demonstrate that min-
mizing weight gain and adverse lipid changes through a
iet and exercise intervention slowed the menopause-
ssociated disease progression seen in the control group.
The results reported here for the perimenopausal/
ostmenopausal women are consistent with results for both
ales and females in the Atherosclerosis Risk In Commu-
ities (ARIC) study. Among ARIC study participants (age
5 to 64 years) the mean annual IMT progression was
.0086 mm among women and 0.0091 mm among men
15). However, the IMT progression rates reported among
remenopausal women of the current study are lower than
oth the males and females in the ARIC study, most likely
wing to the higher age range of the ARIC study. There
ave been very few reports in the literature of the effects of
among the control group by menopausal status, adjusted for age and
lack bars  perimenopausal/postmenopausal. CCA  common carotid
able 2. Mean annual change in IMT by Intervention Status,
djusted for Corresponding Baseline IMT
Variable Intervention Control
p Value
(Intervention vs.
Control)
verage IMT (mm/yr) 0.0051 0.0054 0.867
CA IMT (mm/yr) 0.0057 0.0051 0.738
CA IMT (mm/yr) 0.0013 0.0031 0.530
ulb IMT (mm/yr) 0.0091 0.0131 0.280
CA common carotid artery; ICA internal carotid artery; IMT intima-media/year)
sal; bhickness
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August 4, 2004:579–85 IMT Progression and Exercise Interventionlifestyle intervention on IMT progression rates; most have
een drug trials. In a nested observational study composed
f nearly all males (91%), the Monitored Atherosclerosis
egression Study (MARS) reported that increases in dietary
holesterol, insoluble fiber, BMI, and smoking were all
ignificant predictors of the annual IMT progression rate
mong participants in the placebo arm (16). Each 1-kg/m2
ncrease in BMI associated with a 0.013 mm/year increase
n IMT (16). In a Swedish population of middle-aged
ealthy males with moderately high cardiovascular risk
actor values, an education program resulting in significant
ecreases in BP, lipids, and smoking was not found to be
ssociated with the rate of IMT progression during the
ourse of two years (17). Although slight, the existing
iterature may suggest that the effect of lifestyle intervention
n IMT progression is specific to certain subgroups, such as
hose with existing atherosclerosis as found in the MARS or
erimenopausal women as demonstrated in the current
tudy. Future testing of lifestyle interventions in larger,
epresentative populations is needed.
There are numerous ways in which the menopausal
ransition may affect the vasculature. First, the menopause
ransition is often accompanied by adverse lipid changes
uch as increased LDL-C and decreased HDL-C, whether
ssessed as a categorical status variable or in terms of
ontinuous estrogen measures (7,18).
Second, the menopause transition is also associated with
eight gain (19). Body weight has been linked to the
evelopment of insulin resistance, which has numerous
ascular effects (20). The hyperinsulinemia that accompa-
ies insulin resistance promotes sodium reabsorption
21,22), stimulation of the sympathetic nervous system
23,24), and vascular smooth muscle cell growth (25),
hereas the glycemia accompanying insulin resistance can
ause glycation of the proteins in the arterial wall, which
ave been associated with organ damage and atherosclerosis
26). Additionally, insulin bound to its receptor has potent
igure 2. Mean annual intima-media thickness (IMT) changes (in mm/yea
ars control group; black bars intervention group, adjusted for age an
arotid artery.asodilator effects through endothelium-derived nitric oxide ielease (27), which may be compromised in the insulin-
esistant state. Body weight may contribute to disease
rogression through inflammation (28,29). The presence of
igher levels of circulating immune system cells may in-
rease movement of these cells into the artery wall, leading
o wall thickening and the development of atherosclerosis.
Finally, the menopause transition may be related to
nhanced progression rates through direct effects of chang-
ng hormones on the vasculature. Estradiol has numerous
ascular benefits, such as vasodilation and sympathetic
ervous system effects, decreased collagen production lead-
ng to a decreased elastin/collagen ratio, and effects on
mooth muscle cells (30–38). Progesterone, much like
strogen, also contributes to vasodilation and inhibition of
mooth muscle growth (31). Androgens have vascular effects
s well. Testosterone, although capable of arterial dilation
irectly, blocks the action of various dilation factors and
romotes the action of certain vasoconstrictors (31).
In this study, the diet and exercise intervention slowed
he menopause-associated IMT progression, with signifi-
antly less progression among the intervention group for
omen who had reached perimenopause or postmenopause.
he intervention may have acted through its effects on lipid
evels and weight gain. At the close of the intervention (54
onths), those in the intervention group, compared with
he control group, maintained significantly smaller positive
hanges from baseline in LDL-C (3.5 vs. 8.9 mg/dl),
riglycerides (18.2 vs. 29.9 mg/dl), glucose (1.6 vs. 3.3
g/dl), and body weight (0.18 vs. 5.2 lbs) (11). In
ddition to smaller changes in overall body weight, the
ntervention group had significantly smaller changes in
entral adiposity, specifically2.9 vs. 70.46 cm change in
aist circumference (11), which may promote subclinical
isease progression through its associated insulin resistance
39,40). The intervention group also reported significantly
reater amounts of physical activity than the control group.
hysical activity has been associated with lower IMT values
ong perimenopausal/postmenopausal women by intervention group. Gray
esponding baseline IMT. CCA common carotid artery; ICA internalr) am
d corrn cross-sectional studies (41,42) and may have direct effects
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IMT Progression and Exercise Intervention August 4, 2004:579–85n the vasculature or may operate indirectly by eliciting
avorable changes in risk factors. Finally, changes in the
elative amounts of estrogens versus androgens occurring
hroughout the menopause transition may partially explain
hy the intervention was effective at decreasing menopause-
ssociated IMT progression. These data suggest the perim-
nopause, as opposed to premenopause, as a critical time
eriod for lifestyle intervention. An important question that
hese data cannot answer is whether the lifestyle interven-
ion would have had the same effect if initiated late in
ostmenopause. Future research is needed among post-
enopausal women to address this issue.
Although associations between subclinical disease pro-
ression, menopause, and the diet and exercise intervention
ere consistent for each carotid segment, statistical signif-
cance was not always achieved. Future research will need to
onfirm the effects of menopause, as well as those of diet and
hysical activity on IMT progression rates, in a larger
ample of middle-aged women. Additionally, 92% of the
omen in the WHLP trial were Caucasian. Therefore, the
esults documented here may not be generalizable to other
ace/ethnic groups.
The changes in cardiovascular risk factors during the
enopausal transition combined with hormonal effects on
he vasculature may create an environment in which the
asculature is more prone to the development of atheroscle-
osis. Therefore, the perimenopause provides a critical time
eriod during which to pursue risk-factor modification. The
HLP has demonstrated that a diet and exercise interven-
ion successfully prevents the adverse risk-factor changes
hat accompany the menopause transition (10,11). The data
eported here now document that this intervention slows
enopause-related subclinical atherosclerosis progression,
ighlighting the beneficial effects of risk factor modification
mong perimenopausal women.
eprint requests and correspondence: Dr. Kim Sutton-Tyrrell,
niversity of Pittsburgh, Graduate School of Public Health, 127
arran Hall/130 DeSoto Street, Pittsburgh, Pennsylvania 15261.
-mail: tyrrell@edc.pitt.edu
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